inflammatory diseases and cancer metastasis. The cyclic peptide cyclo(RLsKDK) has been shown to inhibit the enzymatic activity of ADAM8 with high specificity and potency. Herein we report a structure-activity relationship (SAR) study of cyclo(RLsKDK) that involves the synthesis and biological evaluation of the lead compound and structural analogues thereof. This study provides insight into the ligand-receptor
金属
蛋白酶A
DAM8在发炎性疾病和癌症转移的发展中起关键作用。环状肽环(RLsKDK)已显示出以高特异性和高强度抑制A
DAM8的酶活性。本文中,我们报道了环(RLsKDK)的结构-活性关系(
SAR)研究,该研究涉及
铅化合物及其结构类似物的合成和
生物学评估。这项研究提供了对控制环(RLsKDK)与A
DAM8 Disintegrin域结合的
配体-受体相互作用的深刻见解,并为开发炎性疾病和癌症转移的新疗法奠定了基础。